1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prenatal Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 First-Trimester Screening Tests
1.2.3 Second-Trimester Screening Tests
1.2.4 Third-Trimester Screening Tests
1.2.5 Diagnostic Tests
1.3 Market by Application
1.3.1 Global Prenatal Testing Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Pathology Labs
1.3.4 Gynecology Clinics
1.3.5 Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prenatal Testing Market Perspective (2018-2030)
2.2 Prenatal Testing Growth Trends by Region
2.2.1 Prenatal Testing Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Prenatal Testing Historic Market Size by Region (2018-2023)
2.2.3 Prenatal Testing Forecasted Market Size by Region (2023-2030)
2.3 Prenatal Testing Market Dynamics
2.3.1 Prenatal Testing Industry Trends
2.3.2 Prenatal Testing Market Drivers
2.3.3 Prenatal Testing Market Challenges
2.3.4 Prenatal Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prenatal Testing Players by Revenue
3.1.1 Global Top Prenatal Testing Players by Revenue (2018-2023)
3.1.2 Global Prenatal Testing Revenue Market Share by Players (2018-2023)
3.2 Global Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prenatal Testing Revenue
3.4 Global Prenatal Testing Market Concentration Ratio
3.4.1 Global Prenatal Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prenatal Testing Revenue in 2022
3.5 Prenatal Testing Key Players Head office and Area Served
3.6 Key Players Prenatal Testing Product Solution and Service
3.7 Date of Enter into Prenatal Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prenatal Testing Breakdown Data by Type
4.1 Global Prenatal Testing Historic Market Size by Type (2018-2023)
4.2 Global Prenatal Testing Forecasted Market Size by Type (2023-2030)
5 Prenatal Testing Breakdown Data by Application
5.1 Global Prenatal Testing Historic Market Size by Application (2018-2023)
5.2 Global Prenatal Testing Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Prenatal Testing Market Size (2018-2030)
6.2 North America Prenatal Testing Market Size by Country (2018-2023)
6.3 North America Prenatal Testing Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Prenatal Testing Market Size (2018-2030)
7.2 Europe Prenatal Testing Market Size by Country (2018-2023)
7.3 Europe Prenatal Testing Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prenatal Testing Market Size (2018-2030)
8.2 Asia-Pacific Prenatal Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Prenatal Testing Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Prenatal Testing Market Size (2018-2030)
9.2 Latin America Prenatal Testing Market Size by Country (2018-2023)
9.3 Latin America Prenatal Testing Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prenatal Testing Market Size (2018-2030)
10.2 Middle East & Africa Prenatal Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Prenatal Testing Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 LabCorp
11.1.1 LabCorp Company Detail
11.1.2 LabCorp Business Overview
11.1.3 LabCorp Prenatal Testing Introduction
11.1.4 LabCorp Revenue in Prenatal Testing Business (2018-2023)
11.1.5 LabCorp Recent Development
11.2 Sequenom
11.2.1 Sequenom Company Detail
11.2.2 Sequenom Business Overview
11.2.3 Sequenom Prenatal Testing Introduction
11.2.4 Sequenom Revenue in Prenatal Testing Business (2018-2023)
11.2.5 Sequenom Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Detail
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Prenatal Testing Introduction
11.3.4 Quest Diagnostics Revenue in Prenatal Testing Business (2018-2023)
11.3.5 Quest Diagnostics Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Prenatal Testing Introduction
11.4.4 Illumina Revenue in Prenatal Testing Business (2018-2023)
11.4.5 Illumina Recent Development
11.5 Ariosa Diagnostics
11.5.1 Ariosa Diagnostics Company Detail
11.5.2 Ariosa Diagnostics Business Overview
11.5.3 Ariosa Diagnostics Prenatal Testing Introduction
11.5.4 Ariosa Diagnostics Revenue in Prenatal Testing Business (2018-2023)
11.5.5 Ariosa Diagnostics Recent Development
11.6 Natera
11.6.1 Natera Company Detail
11.6.2 Natera Business Overview
11.6.3 Natera Prenatal Testing Introduction
11.6.4 Natera Revenue in Prenatal Testing Business (2018-2023)
11.6.5 Natera Recent Development
11.7 Ravgen
11.7.1 Ravgen Company Detail
11.7.2 Ravgen Business Overview
11.7.3 Ravgen Prenatal Testing Introduction
11.7.4 Ravgen Revenue in Prenatal Testing Business (2018-2023)
11.7.5 Ravgen Recent Development
11.8 Counsyl
11.8.1 Counsyl Company Detail
11.8.2 Counsyl Business Overview
11.8.3 Counsyl Prenatal Testing Introduction
11.8.4 Counsyl Revenue in Prenatal Testing Business (2018-2023)
11.8.5 Counsyl Recent Development
11.9 Eurofins Ntd
11.9.1 Eurofins Ntd Company Detail
11.9.2 Eurofins Ntd Business Overview
11.9.3 Eurofins Ntd Prenatal Testing Introduction
11.9.4 Eurofins Ntd Revenue in Prenatal Testing Business (2018-2023)
11.9.5 Eurofins Ntd Recent Development
11.10 Premaitha Health
11.10.1 Premaitha Health Company Detail
11.10.2 Premaitha Health Business Overview
11.10.3 Premaitha Health Prenatal Testing Introduction
11.10.4 Premaitha Health Revenue in Prenatal Testing Business (2018-2023)
11.10.5 Premaitha Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
